Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dirk Evers, David Ghesquiere

Premium

Dirk Evers is VP of data operations at Molecular Health in Heidelberg, Germany. Previously, he was senior VP of informatics at the New York Genome Center and also served as the director of computational biology at Illumina. He holds a PhD in bioinformatics from Bielefeld University.


NanoString Technologies has appointed David Ghesquiere as senior VP of corporate and business development. Ghesquiere joins NanoString from Dendreon, where he served as senior VP of corporate and business development. He has also served executive roles with OSI Pharmaceuticals (acquired by Astellas) and Aventis Pharmaceuticals (acquired by Sanofi).

Filed under

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.